2014, BioTech and Drug Development - Connected Health Pulse

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

2014

BioTech

Drug Development

Let’s Save the Date and Make Patient Engagement Official in 2022

Society for Participatory Medicine

JANUARY 27, 2022

Healthcare stakeholders such as health systems, pharmaceutical companies, biotech and life sciences firms, and insurance companies serve patients as end users. My mission of advocacy was widened and deepened upon my stage IV colorectal cancer diagnosis in 2014 when I shared my expertise with others fighting for scans and treatments.

BioTech

BioTech Life Science Drug Development Patient Experience

Genomics Startup Human Longevity’s Valuation Falls 80% from $1.6 Billion down to $310M

Lloyd Price

DECEMBER 8, 2018

Craig Venter in 2014—at around $310 million, according to a Human Longevity regulatory filing obtained by Lagniappe Labs LLC, whose Prime Unicorn Index tracks valuations of privately held companies. Existing investors include biotech giant Celgene Corp. , The funding round values the company—co-founded by genomics pioneer J.

Pharmaceuticals

Pharmaceuticals Life Science BioTech Drug Development

Let’s Save the Date and Make Patient Engagement Official in 2022

Genomics Startup Human Longevity’s Valuation Falls 80% from $1.6 Billion down to $310M

Stay Connected